Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 20 of 25

COMPLETED Phase 1

Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer

NCT00983424

COMPLETED NA

Acupressure in Pruritus for Atopic Dermatitis

NCT01074164

TERMINATED Phase 1

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

NCT01060514

TERMINATED NA

Furosemide vs Placebo for Brain Relaxation

NCT01054404

COMPLETED Phase 2

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

NCT00940316

COMPLETED NA

Pre-operative Preparation Using 2% Chlorhexidine Cloth For Shoulder Surgery

NCT01090479

COMPLETED NA

The Effect of Neuraxial Analgesia on Maternal Breastfeeding

NCT01074190

COMPLETED NA

Efficacy of Surgical Preparations in Lumbar Spine Surgery

NCT01105195

COMPLETED NA

Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse Population

NCT01385579

COMPLETED Phase 4

Post Operative Sore Throat and Dexamethasone

NCT01052038

COMPLETED Phase 4

Transverse Abdominis Plane (TAP) Block After Cesarean Delivery

NCT01170702

TERMINATED Phase 1

Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease

NCT01288053

COMPLETED Phase 2

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

NCT00952731

COMPLETED

Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes

NCT01022645

COMPLETED NA

A Pilot Study Testing the Efficacy of a Needling Device for the Treatment of Acne Scars

NCT00974870

COMPLETED Phase 1

Hematopoietic Stem Cell Transplant in Devic's Disease

NCT00787722

COMPLETED Early Phase 1

Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia

NCT00993057

TERMINATED Phase 1

Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia

NCT00985530

COMPLETED NA

Cerebral Autoregulation Monitoring During Cardiac Surgery

NCT00981474

COMPLETED

BRAVO: Biomarker Risk Assessment in Vulnerable Outpatients

NCT02276781

COMPLETED NA

The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

NCT01009645

COMPLETED NA

Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment

NCT00997139

COMPLETED Phase 1

Effectiveness of a Technology Assisted Behavioral Intervention in Assisting People With Major Depressive Disorder

NCT00719979

COMPLETED Phase 2

Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

NCT00956930

COMPLETED Phase 2

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

NCT00720356

COMPLETED Phase 2

Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease

NCT00909545

TERMINATED Phase 1

Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome

NCT01009502

COMPLETED NA

A Comparison of the Detection of Hypoventilation During Deep Sedation Utilizing Nasal End Title CO@ Versus Transcutaneous CO2 Measurement Techniques

NCT00954733

COMPLETED

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

NCT00879944

COMPLETED

The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)

NCT00430612

COMPLETED NA

Enhanced Prescription Drug Label to Improve Patient Understanding and Use

NCT00973180

COMPLETED Phase 4

Efficacy of Pregabalin in Patients With Radicular Pain

NCT00908375

COMPLETED Phase 3

Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial

NCT00852592

COMPLETED Phase 2

Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide

NCT00990652

COMPLETED Phase 1

Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases

NCT00858429

COMPLETED NA

Quantitative Evaluation of Skin Shrinkage Caused by a Non-invasive Tightening Device

NCT00894244

COMPLETED NA

Comparison of 25-hydroxy Vitamin D Level in Caucasian Women Receiving Vitamin D Supplementation and Not Receiving Supplementation: a Randomized Controlled Trial.

NCT00882505

COMPLETED Phase 4

Study of Glycemic Control on Liver Transplantation Outcomes

NCT01211730

TERMINATED NA

Balloon Colonoscopy for Incomplete Colonoscopy

NCT00935857

COMPLETED NA

Point-of-Care Computed Tomography (CT) Chronic Rhinosinusitis Study

NCT00871286

COMPLETED NA

Skin Care for Cancer Patients: A Product Satisfaction Survey

NCT00871429

TERMINATED NA

Outreach for Patients That Are Newly Eligible for Colorectal Cancer Screening

NCT00860249

COMPLETED Phase 1

Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma

NCT00846131

COMPLETED Phase 2

Study of Alwextin® Cream in Treating Epidermolysis Bullosa

NCT00825565

COMPLETED NA

Pilot Study of Stellate Ganglion Injection to Provide Relief From Hot Flushes

NCT00992914

COMPLETED NA

NOTES-Assisted Laparoscopic Cholecystectomy Surgery

NCT00848146

TERMINATED NA

Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps

NCT00870961

COMPLETED

Determine the Relationship Between Circadian Rhythms and Nocturnal Asthma

NCT00891189

COMPLETED Phase 4

Temperature Control in Central Fever in the Neuro-ICU

NCT00751634

COMPLETED

Osteoporosis Research Registry

NCT01223300

← Previous Page 20 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.